PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23764356-6	2013	Liver histopathology also showed that puerarin reduced the incidence of liver lesions induced by CCl4.	puerarin	38-46	C-C motif chemokine ligand 4	Rattus norvegicus	97-101	
27677221-1	2016	In this study, we aim to explore the potential benefits of puerarin on metabolic function of liver fibrosis (LF) rat induced by carbon tetrachloride (CCl4), and to investigate with the underlying molecular mechanism targeted on liver and pancreas tissues.	puerarin	59-67	C-C motif chemokine ligand 4	Rattus norvegicus	150-154	
27677221-8	2016	Our findings demonstrate that puerarin contributes to attenuating the metabolic dysfunctions of CCl4-damaged liver and pancreas, in which the possible mechanisms may be linked to inhibition of inflammatory stress and normalization of metabolic homoeostasis in the liver and pancreas.	puerarin	30-38	C-C motif chemokine ligand 4	Rattus norvegicus	96-100	
23764356-1	2013	The protective effects of puerarin on liver damage were evaluated by carbon tetrachloride (CCl4)-induced hepatotoxicity in rats.	puerarin	26-34	C-C motif chemokine ligand 4	Rattus norvegicus	91-95	
23764356-4	2013	In addition, puerarin at different doses significantly decreased (p<0.05) the level of hepatic thiobarbituric acid reactive substances compared to the CCl4-treated group.	puerarin	13-21	C-C motif chemokine ligand 4	Rattus norvegicus	154-158	
23764356-5	2013	Furthermore, the treatment of puerarin was also found to significantly increase the activities of superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, and glutathione content at least 40%, 12%, 25%, 52%, 17% and 44% in the liver of CCl4-treated rats, respectively.	puerarin	30-38	C-C motif chemokine ligand 4	Rattus norvegicus	285-289	
23764356-7	2013	The results suggest that puerarin exhibits potent hepatoprotective effects on CCl4-induced liver damages in rats, and that the hepatoprotective effects of puerarin may be due to both the inhibition of lipid peroxidation and to increase of antioxidant enzymes activity.	puerarin	25-33	C-C motif chemokine ligand 4	Rattus norvegicus	78-82	
23146695-0	2013	Puerarin mediates hepatoprotection against CCl4-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function.	puerarin	0-8	C-C motif chemokine ligand 4	Rattus norvegicus	43-47	
23500774-0	2013	Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-gamma expression and inhibition of PI3K/Akt pathway.	puerarin	25-33	C-C motif chemokine ligand 4	Rattus norvegicus	37-41	
23500774-2	2013	In this study, we aimed to investigate the therapeutic effects of puerarin (PR), an active ingredient from kudzu root, on CCl4-induced HF rats.	puerarin	66-74	C-C motif chemokine ligand 4	Rattus norvegicus	122-126